Template:Neuroblastoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma epidemiology and demographics|Epidemiology & Demographics]]
[[Neuroblastoma causes|Causes]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma risk factors|Risk Factors]]
[[Neuroblastoma differential diagnosis|Differentiating Neuroblastoma from other Diseases]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma screening|Screening]]
[[Neuroblastoma epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma causes|Causes of Neuroblastoma]]
[[Neuroblastoma risk factors|Risk Factors]]
|-  
|-  
!
!
Line 64: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma differential diagnosis|Differentiating Neuroblastoma from other Diseases]]
[[Neuroblastoma screening|Screening]]
|-  
|-  
!
!
Line 70: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Neuroblastoma natural history|Natural History, Complications & Prognosis]]
[[Neuroblastoma natural history|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 82: Line 82:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Neuroblastoma history and symptoms|History & Symptoms]]
[[Neuroblastoma history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Neuroblastoma laboratory tests|Lab Tests]]
[[Neuroblastoma laboratory tests|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Neuroblastoma chest x ray|Chest X Ray]]
[[Neuroblastoma chest x ray|X Ray]]
|-  
|-  
!
!
Line 125: Line 125:
!
!
[[Neuroblastoma echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Neuroblastoma echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Neuroblastoma other imaging findings|Other Imaging Findings]]
|-  
|-  
!
!
Line 154: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Neuroblastoma primary prevention|Primary Prevention]]
[[Neuroblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 160: Line 166:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Neuroblastoma secondary prevention|Secondary Prevention]]
[[Neuroblastoma future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
[[Neuroblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
Case Studies
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Neuroblastoma future or investigational therapies|Future or Investigational Therapies]]
[[Neuroblastoma case study one|Case #1]]
|-  
|-  
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Revision as of 17:22, 10 September 2012